Dynavax Technologies Corporation (DVAX)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	227,802	216,087	204,826	189,728	182,117	242,214	292,330	418,713	460,530	474,584	416,363	281,190	265,870	160,304	121,507	85,084	32,641	22,989	18,033	20,397
Revenue (ttm)	US$ in thousands	277,247	260,811	249,695	236,149	232,284	361,180	459,401	655,616	722,683	733,261	673,796	470,099	439,442	263,922	169,066	118,967	46,551	37,571	34,732	40,365
Gross profit margin		82.17%	82.85%	82.03%	80.34%	78.40%	67.06%	63.63%	63.87%	63.73%	64.72%	61.79%	59.82%	60.50%	60.74%	71.87%	71.52%	70.12%	61.19%	51.92%	50.53%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $227,802K ÷ $277,247K
= 82.17%

Dynavax Technologies Corporation's gross profit margin has shown fluctuations over the years as per the provided data. The trend indicates an increasing pattern, starting at around 50% in March 2020 and reaching a peak of 82.85% by September 30, 2024, before slightly dropping to 82.17% by December 31, 2024.

The company has seen significant improvements in its gross profit margin from 2020 to 2024, reflecting potentially better pricing strategies, cost control measures, or operational efficiencies. However, the slight decline in the last quarter of 2024 may warrant further investigation to understand the factors driving this change. Overall, Dynavax's increasing gross profit margin over the years suggests positive developments in its cost structure and revenue generation.